Search Results
May 18, 2026, 08:05 ET FDA Approves IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi), First Biosimilars to Simponi® (golimumab) and Simponi Aria® (golimumab); Accord BioPharma to Lead U.S. Commercialization
www.fda.gov/medwatch.IMMGOLIS (golimumab-sldi) injection is supplied in a 50 mg/0.5 mL and 100 mg/mL single-dose prefilled syringe.IMMGOLIS INTRI (golimumab-sldi) injection is supplied in a 50 mg/4 mL (12.5 mg/mL) solution in a single-dose vial.Click here for
More news about: Accord BioPharma
May 18, 2026, 07:54 ET Biotheryx Announces Data from its Phase 1 Dose Escalation Study of BTX-9341, a First-in-Class, Potent and Selective CDK4/6 Degrader, for the Treatment of Advanced/Metastatic HR+/HER2- Breast Cancer
n-study-of-btx-9341-a-first-in-class-potent-and-selective-cdk46-degrader-for-the-treatment-of-advancedmetastatic-hrher2--breast-cancer-302774140.htmlSOURCE Biotheryx, Inc.
More news about: Biotheryx, Inc.
May 18, 2026, 07:00 ET Compugen Reports First Quarter 2026 Results
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered by AI/ML, today reported financial results for the first quarter of 2026 and provided a corporate update. "Q1 2026 reflects continued execution across
More news about: Compugen Ltd.
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
people who've been underserved by the existing category."FolinicActive™ is available in two adult formats: a USDA Organic liquid (30 mL, 60 servings at 0.50 mL daily) and a vegan capsule (60 count, 1 capsule daily). Both deliver identical active ingredients at identical doses—1 mg folinic acid, 1,000
More news about: Triquetra Health LLC
May 18, 2026, 07:00 ET Triquetra Health Launches FolinicActive™ Adult Liquid--First Multi-Pathway Active Folate with Complete Tri-Cofactor System
complete folate solutions for every need actually looks like."FolinicActive Adult Liquid delivers 1 mg folinic acid (as calcium folinate) per 0.50 mL serving alongside the Complete Tri-Cofactor System: 1,000 mcg Vitamin B-12 as a tri-blend (80% methylcobalamin, 10% adenosylcobalamin, 10% hydroxocobalamin),
More news about: Triquetra Health LLC
May 18, 2026, 07:00 ET Bracco and ACIST Medical Systems Announce U.S. FDA Clearance of ACIST Pro™ Diagnostic System
real-time precision. Clinical use of the ACIST CVi® system has demonstrated outcomes compared to manual injection, including on average 45ml reduction of contrast use1, a 30 percent reduction in CI-AKI1,2, and an average of five minutes saved per case.3"Expanding
More news about: Bracco Group
May 16, 2026, 17:36 ET Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Coast Medical Service, Inc., for Alleged Failure to Provide Required Meal Periods and Rest Periods
k-de-blouw-llp-filed-a-lawsuit-against-coast-medical-service-inc-for-alleged-failure-to-provide-required-meal-periods-and-rest-periods-302773172.htmlSOURCE Blumenthal Nordrehaug Bhowmik De Blouw LLP
More news about: Blumenthal Nordrehaug Bhowmik De Blouw LLP
May 15, 2026, 08:01 ET Prime Video and (STRING) Theory Launch Limited-Edition Off Campus Fragrance Collection
vaporLimited Edition Perfume Oil Rollerball, $24.97 (15ml)Feral Haze for Her – Hannah Edition Notes of vanilla orchid, dark rum, amber, tonka bean, muskLimited Edition Perfume Oil Rollerball, $24.97 (15ml)For more information about String Theory visit amazon.com/stringtheoryfragrance and
More news about: STRING THEORY
May 15, 2026, 08:00 ET biohack skin's longevity with futurecode booster
care product to boost your routine. May be used up to four times per day.AvailabilityFutureCode Booster comes in a 1.0 FL OZ / 30 mL bottle. Find it at authorized Dermalogica spas, salons and skin centers, as well as Ulta, starting on May 15, 2026.About DermalogicaUsed
More news about: Dermalogica
May 14, 2026, 19:07 ET Consumer Watchdog Reports: Assembly Kills Landmark Legislation Requiring Independent Audits of Utility Wildfire Spending, Rebuke to Wildfire Survivors As Utilities Seek Bailout Worth Billions
lation-requiring-independent-audits-of-utility-wildfire-spending-rebuke-to-wildfire-survivors-as-utilities-seek-bailout-worth-billions-302772988.htmlSOURCE Consumer Watchdog
More news about: Consumer Watchdog
May 14, 2026, 17:02 ET SIDUS SPACE REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS WITH Q1 YEAR OVER YEAR IMPROVEMENT IN REVENUE AND GROSS MARGIN
solutions, including satellite manufacturing and technology integration, AI-driven space-based data solutions, mission planning and management operations, AI/ML products and services, and space and defense hardware manufacturing. With its mission of Space Access Reimagined®, Sidus Space is committed to rapid
More news about: Sidus Space, Inc.
May 14, 2026, 16:23 ET Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
approved in 2 mg and 4 mg prefilled pen formats, providing:0.25 mg or 0.5 mg doses (2 mg pen; 0.68 mg/mL) 1 mg doses (4 mg pen; 1.34 mg/mL)Apo-Semaglutide Injection™ is administered using a prefilled pen with instructions for use consistent with brand‑name
More news about: Apotex Inc.
May 14, 2026, 09:00 ET Fastino Labs, Creator of GLiNER, Releases Two State-of-the-Art Language Models 1,000x Smaller Than Frontier
Pioneer watches live requests, identifies where a model is failing, and retrains and promotes new checkpoints when they outperform the current one, with no ML engineer required and no fine-tuning code to write. Customers see an average 30% accuracy lift on agentic tasks such as classification and extraction
More news about: Fastino Labs
May 14, 2026, 08:30 ET GLG Provides Expert Insights on Bloomberg's ASKB
artificial intelligence (AI) in the finance domain – including machine learning (ML), natural language processing (NLP), information retrieval (IR), time-series analysis, generative models, and agentic AI architectures – to help process
More news about: GLG
May 14, 2026, 08:20 ET T2S Solutions Selected for Missile Defense Agency HAIRST Effort
Community, and industry partners. Its expertise spans advanced Defense, Space, Sensing, Positioning, Navigation, and Timing (PNT), Electronic Warfare, AI/ML, and mission systems technologies. T2S is headquartered in Belcamp, Maryland, with major operations and integration capabilities in Huntsville, Alabama
More news about: T2S Solutions
May 14, 2026, 08:00 ET DESILO's 5th-Generation FHE Scheme 'GL' Recognized by International Academic Community -- Two Papers Simultaneously Accepted at IACR Crypto 2026
GL scheme offers a meaningful breakthrough to overcome this limitation. By designing a structure optimized for matrix operations — the backbone of AI/ML — the scheme achieves performance improvements of hundreds of times over 4th-generation technology in core computation areas. This is seen as a significant
More news about: DESILO
May 14, 2026, 07:19 ET Resurge Therapeutics Announces Positive Clinical Results from Two Studies of Its Intraprostatic Drug Elution Platform for Benign Prostatic Hyperplasia (BPH) at AUA 2026
Prostate Symptom Score (IPSS) improvement of 15 points at 1 year after a single treatment. Maximum urinary flow rate (Qmax) improved by approximately 4 mL/s, with 80% of patients achieving clinically significant symptom improvement. No serious drug- or procedure-related adverse events or systemic drug toxicity
More news about: Resurge Therapeutics
May 14, 2026, 07:05 ET Cypherpunk Technologies Reports First Quarter 2026 Financial Results
("OS") in patients with high levels of DKK1 using the new plasma DKK1 biomarker assay.50% of patients had DKK1-high levels > 380 pg/ml, and in this subgroup of patients (n=87):ORR was 42% (including one complete response) in the Sirexatamab Arm vs. 16% ORR in the
More news about: Cypherpunk Technologies Inc.
May 14, 2026, 07:05 ET Cypherpunk Technologies Reports First Quarter 2026 Financial Results
("OS") in patients with high levels of DKK1 using the new plasma DKK1 biomarker assay.50% of patients had DKK1-high levels > 380 pg/ml, and in this subgroup of patients (n=87):ORR was 42% (including one complete response) in the Sirexatamab Arm vs. 16% ORR in the
More news about: Cypherpunk Technologies Inc.
May 13, 2026, 22:09 ET METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals
d-drug-delivery-company-debuts-on-the-hong-kong-stock-exchange-the-spacex-of-pharmaceuticals-ushers-in-a-new-era-of-biopharmaceuticals-302771717.htmlSOURCE METiS TechBio
More news about: METiS TechBio
May 13, 2026, 17:01 ET Manulife Reports First Quarter 2026 Results
production‑ready environments and enabling initial scalable use cases, while leveraging new strategic partnerships with Akka10 and Adaptive ML11. In addition, our developers across the organization continued to adopt assisted and autonomous AI capabilities, increasing their productivity
More news about: Manulife Financial Corporation
May 13, 2026, 17:01 ET Manulife Reports First Quarter 2026 Results
production‑ready environments and enabling initial scalable use cases, while leveraging new strategic partnerships with Akka10 and Adaptive ML11. In addition, our developers across the organization continued to adopt assisted and autonomous AI capabilities, increasing their productivity
More news about: Manulife Financial Corporation
May 13, 2026, 14:11 ET Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
Famotidine Injection USP, 20 mg/2 mL (10 mg/mL) is bioequivalent to the reference listed drug (RLD), Pepcid® Injection, 10 mg/mL of Merck Sharp & Dohme Corp. It is indicated for intravenous use in some hospitalized patients with
More news about: Lupin Pharmaceuticals, Inc.
May 13, 2026, 12:30 ET Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe
structural inflection point for the sector. Healthcare AI builders now face tightening regulation in every major market - from the FDA's expanded AI/ML guidance in the U.S. to new lifecycle accountability requirements in Canada and the UK. But Europe is the most acute case. In the past four weeks,
More news about: Corti
May 13, 2026, 12:30 ET Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe
structural inflection point for the sector. Healthcare AI builders now face tightening regulation in every major market - from the FDA's expanded AI/ML guidance in the U.S. to new lifecycle accountability requirements in Canada and the UK. But Europe is the most acute case. In the past four weeks,
More news about: Corti